Last reviewed · How we verify
NCT04149028
Platelet Rich Plasma Injection Into Ovary of Patients With Premature Ovarian Insufficiency
NA trial testing PRP injection inside the ovary by laparoscoy. The injection volume is 2 ml in Premature Ovarian Failure in 16 participants. Completed in 31 December 2022.
31 December 2022
Quick facts
| Lead sponsor | Tanta University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 16 |
| Start date | 1 December 2019 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- PRP injection inside the ovary by laparoscoy. The injection volume is 2 ml
Conditions studied
- Premature Ovarian Failure — all drugs for Premature Ovarian Failure →
Sponsor
Tanta University
Who can join
Adults 18 to 35, female only, with Premature Ovarian Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
All encountered cases with POI will be assessed and examined then investigated. Eligible cases will be included in the study
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Therapeutic roles of platelet-rich plasma to restore female reproductive and endocrine dysfunction.
Wang X, Li J, Lu W, Gao F, et al · · 2024 · cited 8× · PMID 38654928 · DOI 10.3389/fendo.2024.1374382 -
Platelet-Rich Plasma (PRP) in Reproductive Medicine: A Critical Review of PRP Therapy in Low-Reserve and Premature Ovarian Insufficiency.
Moustakli E, Potiris A, Zikopoulos A, Zachariou A, et al · · 2025 · cited 2× · PMID 40427083 · DOI 10.3390/biomedicines13051257 -
Research trends on platelet-rich plasma in improving ovarian dysfunction: A bibliometric and visualization analysis.
Liu F, Li J, Li J, Lan M, et al · · 2025 · PMID 41079455 · DOI 10.1016/j.reth.2025.09.010
Verify or expand the search:
- PubMed search for NCT04149028
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Premature Ovarian Failure
Currently open trials in the same condition.
- NCT05740579 — The Danish TURNER Cryopreservation Study · NA · recruiting
- NCT05462379 — Autologous Heterotopic Fresh Ovarian Graft in Woman With LACC Eligible for Pelvic Radiotherapy Treatment. · Phase 1, PHASE2 · active not recruiting
- NCT04815213 — The Use of Expandeded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans · Phase 1 · active not recruiting
- NCT04390308 — Is There A Role For Mechanical Stimulation In Ovarian Follicular Activation? · recruiting
- NCT04381299 — Will Autologous Platelet Rich Plasma Able To Restore Ovarian Function? · active not recruiting
Other Tanta University trials
Trials by the same sponsor.
- NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
- NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
- NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
- NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
- NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04149028 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tanta University
- Last refreshed: 17 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04149028.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing